Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

748 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development and Validation of Staging Systems for AA Amyloidosis.
Basset M, Schönland SO, Obici L, Günther J, Riva E, Dittrich T, Milani P, Ferretti VV, Pasquinucci E, Foli A, Kimmich C, Nanci M, Bellofiore C, Benigna F, Beimler J, Benvenuti P, Fabris F, Mussinelli R, Nuvolone M, Klersy C, Albertini R, Merlini G, Hegenbart U, Palladini G, Blank N. Basset M, et al. Among authors: klersy c. J Am Soc Nephrol. 2024 Jun 1;35(6):782-794. doi: 10.1681/ASN.0000000000000339. Epub 2024 Mar 21. J Am Soc Nephrol. 2024. PMID: 38512269 No abstract available.
A risk-stratification model based on the initial concentration of the serum monoclonal protein and MYD88 mutation status identifies a subset of patients with IgM monoclonal gammopathy of undetermined significance at high risk of progression to Waldenström macroglobulinaemia or other lymphoproliferative disorders.
Varettoni M, Zibellini S, Boveri E, Klersy C, Candido C, Rattotti S, Ferretti VV, Defrancesco I, Mangiacavalli S, Nizzoli ME, Flospergher E, Zerbi C, Bergamini F, Benvenuti P, Brociner M, Merati G, Paulli M, Arcaini L. Varettoni M, et al. Among authors: klersy c. Br J Haematol. 2019 Nov;187(4):441-446. doi: 10.1111/bjh.16086. Epub 2019 Jul 5. Br J Haematol. 2019. PMID: 31276195 Free article.
Bioelectrical impedance vector analysis-derived phase angle predicts survival in patients with systemic immunoglobulin light-chain amyloidosis.
Caccialanza R, Cereda E, Klersy C, Milani P, Cappello S, Martinelli V, Turri A, Basset M, Borioli V, Nuvolone M, Caraccia M, Lavatelli F, Masi S, Lobascio F, Foli A, Merlini G, Palladini G. Caccialanza R, et al. Among authors: klersy c. Amyloid. 2020 Sep;27(3):168-173. doi: 10.1080/13506129.2020.1737004. Epub 2020 Mar 26. Amyloid. 2020. PMID: 32212933 Clinical Trial.
Validation of a new prognostic body composition parameter in cancer patients.
Cereda E, Caraccia M, Klersy C, Cappello S, Turri A, Borioli V, Stobäus N, Giannoni A, Arcaini L, Benazzo M, Palladini G, Pedrazzoli P, Norman K, Caccialanza R. Cereda E, et al. Among authors: klersy c. Clin Nutr. 2021 Feb;40(2):615-623. doi: 10.1016/j.clnu.2020.06.011. Epub 2020 Jun 23. Clin Nutr. 2021. PMID: 32636113
Bortezomib, Melphalan, and Dexamethasone for Light-Chain Amyloidosis.
Kastritis E, Leleu X, Arnulf B, Zamagni E, Cibeira MT, Kwok F, Mollee P, Hájek R, Moreau P, Jaccard A, Schönland SO, Filshie R, Nicolas-Virelizier E, Augustson B, Mateos MV, Wechalekar A, Hachulla E, Milani P, Dimopoulos MA, Fermand JP, Foli A, Gavriatopoulou M, Klersy C, Palumbo A, Sonneveld P, Johnsen HE, Merlini G, Palladini G. Kastritis E, et al. Among authors: klersy c. J Clin Oncol. 2020 Oct 1;38(28):3252-3260. doi: 10.1200/JCO.20.01285. Epub 2020 Jul 30. J Clin Oncol. 2020. PMID: 32730181 Clinical Trial.
Prospective urinary albumin/creatinine ratio for diagnosis, staging, and organ response assessment in renal AL amyloidosis: results from a large cohort of patients.
Basset M, Milani P, Ferretti VV, Nuvolone M, Foli A, Benigna F, Nanci M, Bozzola M, Ripepi J, Sesta M, Russo F, Bosoni T, Klersy C, Albertini R, Merlini G, Palladini G. Basset M, et al. Among authors: klersy c. Clin Chem Lab Med. 2022 Jan 13;60(3):386-393. doi: 10.1515/cclm-2021-0912. Print 2022 Feb 23. Clin Chem Lab Med. 2022. PMID: 35018751 Free article.
748 results